- Home
- EM vs SCPH Comparison
EM vs SCPH Comparison
Compare EM & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EM
- SCPH
- Stock Information
- Founded
- EM 2017
- SCPH 2013
- Country
- EM China
- SCPH United States
- Employees
- EM N/A
- SCPH N/A
- Industry
- EM Other Consumer Services
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- EM Consumer Discretionary
- SCPH Health Care
- Exchange
- EM Nasdaq
- SCPH Nasdaq
- Market Cap
- EM 286.5M
- SCPH 299.0M
- IPO Year
- EM 2021
- SCPH 2017
- Fundamental
- Price
- EM $1.35
- SCPH $5.61
- Analyst Decision
- EM Hold
- SCPH Buy
- Analyst Count
- EM 1
- SCPH 3
- Target Price
- EM $1.25
- SCPH $12.00
- AVG Volume (30 Days)
- EM 1.9M
- SCPH 2.3M
- Earning Date
- EM 11-26-2025
- SCPH 11-12-2025
- Dividend Yield
- EM N/A
- SCPH N/A
- EPS Growth
- EM N/A
- SCPH N/A
- EPS
- EM N/A
- SCPH N/A
- Revenue
- EM $259,541,587.00
- SCPH $49,969,000.00
- Revenue This Year
- EM $3.30
- SCPH $108.95
- Revenue Next Year
- EM $5.26
- SCPH $78.30
- P/E Ratio
- EM N/A
- SCPH N/A
- Revenue Growth
- EM N/A
- SCPH 107.79
- 52 Week Low
- EM $0.50
- SCPH $1.94
- 52 Week High
- EM $1.45
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- EM 64.81
- SCPH 63.30
- Support Level
- EM $1.34
- SCPH $4.33
- Resistance Level
- EM $1.37
- SCPH $5.62
- Average True Range (ATR)
- EM 0.03
- SCPH 0.04
- MACD
- EM -0.00
- SCPH 0.00
- Stochastic Oscillator
- EM 71.43
- SCPH 78.57
About EM Smart Share Global Limited
Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.